The Washington Post, in a separate story: Implementation of the new law continued with the Obama administration last week telling small biotech firms how they can apply for grants and tax credits, worth up to $5 million each. "In a news briefing, an administration official said she did not know how much it will cost to administer the $1 billion program, which calls for the government to review each application's scientific merits. The announcement was the latest in a series by the administration explaining how the new law is being implemented and showcasing provisions that deliver tangible benefits to various constituencies. Earlier, the administration unveiled rules governing tax credits for small businesses that insure their workers, financial aid for companies that cover early retirees and opportunities for young adults to stay on their parents' health plans." The credits are for so-called "therapeutic discovery projects." Other credits give money for therapies that show "potential to treat unmet needs or making progress toward curing cancer" (Hilzenrath, 5/24).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.